Leadership

Jeff Margolis is a healthcare and IT entrepreneur, systems design innovator, and former CEO and Chairman of Welltok, a leading healthcare consumer activation company. He previously founded, chaired, and led TriZetto, the first vertical SaaS enterprise solution serving more than 130 million insured lives. Jeff also originated the systematic concepts of Integrated Healthcare Management and Health Optimization, notably codifying both into commercial data and software companies. He serves on the boards of TriNetX, DNAnexus, Get-Grin Inc., and Brightside Health, and chairs the Advisory Board at the Center for Digital Transformation at the University of California, Irvine. He is a Senior Advisor to Blackstone and an NACD Board Leadership Fellow. Jeff is also a published author of ‘Not Just in Sickness But Also in Health’ and ‘The Healthcare Cure’, and a frequent industry speaker.

Jeffrey Brown, PhD, is an internationally recognized expert in the use of real-world data to meet regulatory and evidentiary needs for medical product development and the assessment of real-world data quality. He has more than 25 years’ experience in using real-world data in research, most recently as an Associate Professor in the Department of Population Medicine at Harvard Medical School and as a trusted consultant to numerous research groups and pharma companies. Dr. Brown holds a master’s degree in Economics from Tufts University and a PhD in Social Policy from Brandeis University.

Recognized for her leadership excellence in both sales and management, Shields Carstarphen spent 16 years with PPD, a part of Thermo Fisher Scientific, where she most recently served as Senior Vice President of Commercial. Shields’ career began in business development roles at Rho, Medifacts International, and TIBCO Software. She earned her bachelor’s degree at the University of North Carolina at Chapel Hill.

Bringing over 20 years of human resources leadership experience in the technology sector, Jennifer Eagan is responsible for people programs at TriNetX, including talent acquisition, employee training and development, organization planning, and creating a dynamic company culture. Before joining TriNetX, Jennifer was the Global Director of Human Resources at Cryptzone.

Linda Fenton is an experienced executive leader and Chief Financial Officer with a strong background in both public and private companies within the healthcare technology sector. As Principal of SpringBoard Strategic Advisors, she provides interim and fractional CFO services, helping organizations navigate periods of transition and bridge financial leadership gaps. Her work also includes coaching and advising CFOs who are new to the role. Linda holds an MBA, a Master of Health Administration, and a Bachelor of Science in Business and Management.

Andrew Kopelman is a seasoned life sciences attorney with nearly two decades of experience focused on helping high-growth technology companies navigate complex legal and regulatory landscapes, solve novel issues, and drive successful outcomes. Andrew joined TriNetX from Medidata Solutions, where he served as DGC, SVP, and Chief Privacy Counsel, and has extensive private practice experience, counseling life sciences and technology companies on IP, patent litigation, and transactions. Andrew earned his BA in Chemistry from Carleton College and his JD from Cardozo School of Law.

Steve is a technology and business leader with over 20 years of experience in clinical research, health analytics, consulting, and software development. Prior to TriNetX, Steve built and led engineering teams at Perceptive Informatics and PAREXEL, and before that, was a technology consultant for several Fortune 1000 and startup companies and co-founder of an internet infrastructure company. Steve has a BS in Engineering from Cornell University and an MBA from Babson College.

Elizabeth Schwert brings deep expertise in corporate development, enterprise strategy, and finance to her role leading TriNetX’s inorganic growth initiatives. Since joining TriNetX in 2023, she has driven the company’s most consequential transactions, including a $200 million strategic collaboration with Regeneron, the acquisition of Zetta Genomics, and the establishment of a joint venture with Fujitsu. In addition to corporate development, Elizabeth leads TriNetX’s enterprise strategic planning process. Prior to TriNetX, Elizabeth built her career in healthcare investing, including roles at Berkshire Partners and SV Health Investors, where she executed growth-stage investments across healthcare services and digital health. Elizabeth holds an MBA from Harvard Business School, where she was named a Baker Scholar, and a BS in Engineering from the University of Pennsylvania.